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Protein tyrosine phosphatases (PTPs) are central players in many biological processes. In this 
issue, Barr et al. (2009) analyze 22 different PTP structures to define their common and unique 
features. This effort provides key insights into the regulation of PTP activity that could lead to the 
development of new therapeutics.Phosphorylated tyrosine residues serve 
as unique and exquisitely sensitive 
switches for the initiation and termination 
of intracellular signals. Although cells 
have evolved several protein domains 
that recognize phosphotyrosine in the 
context of a wide number of proteins, 
the protein tyrosine phosphatases 
(PTPs) remain the most divergent and 
ubiquitously expressed gene families 
with this capacity. The human genome 
contains 107 PTPs, which recognize and 
remove phosphate moieties attached to 
tyrosine/serine/threonine containing pro-
tein substrates. Based on their primary 
sequence, only 38 of these enzymes 
appear to be uniquely specific to phos-
photyrosine and this group is so diver-
gent that they have been further sub-
classified into 17 subgroups of enzymes. 
This diversity likely reflects the richness 
of the interactions of PTPs with the cell 
signaling machinery. In this issue, Barr et 
al. (2009) examine 22 PTP structures and 
present several new insights into sub-
strate recognition and catalytic activity 
that will be of interest to both the PTP 
community and those seeking to identify 
PTP modulators for the treatment of vari-
ous diseases.
In the 20 years since their discovery, 
much of what we have learned about 
the mechanism of action of the typical 
PTP catalytic domain comes from crys-
tal structures of a relatively small sub-
set of these proteins. The PTP catalytic 
domains of these enzymes are generally 
easily purified and obtained in very active 
extracts. And although they display 
poor substrate specificity in vitro, they 
are extremely specific in vivo. This was 
recently demonstrated for PTP1B, which 
recognizes only one of multiple tyrosine phosphorylation sites on cortactin, a 
protein that regulates actin branching 
(Stuible et al., 2008). Therefore, to reveal 
their common features, as well as the 
uniqueness of the different subgroups of 
PTPs, an assessment of a larger pool of 
PTP structures has been needed.
Barr et al. (2009) have now analyzed 
the variation in surface properties of 22 
human PTP family members. In addition 
to the many individual particularities that 
are revealed about each, they present 
the discovery of a new atypical confor-
mation for the catalytic (WPD) loop in 
which the loop is open even when the 
catalytic pocket is bound by substrate. 
They also assay a broad range of phos-
phopeptide substrates and model some 
of those peptides onto PTP structures. 
Two sets of findings particularly stand 
out from their work. First, the system-
atic comparison of these different PTPs 
allowed the authors to show that a sec-
ondary substrate-binding pocket, ini-
tially reported for PTP1B (Barford et al., 
1994), can also be found in most other 
PTPs. The secondary substrate-bind-
ing site is separated from the catalytic 
pocket by a small gateway region, which 
consists of a direct groove between 
the catalytic pocket and the secondary 
substrate binding site that is flanked by 
two bulky residues. Barr and colleagues 
examined these two features in all of 
their PTP structures and were able to 
categorize most of their candidate PTPs 
into five subsets of enzymes based on 
whether those two structural elements 
were “open” or “closed.” For example, 
they observed that the secondary sub-
strate-binding site could be anchored 
on a basic residue (Arg24 in PTP1B) or a 
cysteine for the R8 subgroup (IA2, IA2β). Cell 136Alternatively, other PTPs, such as STEP 
and HePTP, possess an aromatic or a 
proline residue at that site that eliminates 
the possibility of the region acting as a 
substrate-binding pocket. Moreover, 
they note that the gateway region is either 
“open” with sufficient space for a pep-
tide to come into the groove or “closed” 
by the presence of bulky residues that 
prevent direct access between the sec-
ondary substrate-binding pocket and 
the catalytic pocket. The gateway region 
and the secondary substrate-binding 
site are likely to be crucial for substrate 
specificity. Importantly, PTP1B is already 
targeted by inhibitors that simultane-
ously obstruct the catalytic pocket and 
the secondary substrate-binding pocket 
(Zhang and Zhang, 2007). The authors’ 
recognition that most members of the 
PTP family have both a catalytic pocket 
and a secondary substrate-binding site 
provides an interesting and favorable 
rationale for the further development of 
such inhibitors.
A second general feature of PTPs 
that is clarified by this new work is how 
homodimerization of receptor PTPs 
inhibits their activity. Receptor-like PTPs 
(RPTPs) comprise an extracellular seg-
ment, a transmembrane region, and an 
intracellular section containing one or two 
catalytic domains. In contrast to receptor 
tyrosine kinases that are activated by pair-
ing, dimerization of RPTPs inhibits their 
activity. A mechanism for their inhibition 
through dimerization was first proposed 
by Bilwes et al. (1996) who noticed that 
RPTPα D1 crystals are indeed dimers. 
In their structure, a segment of 24 amino 
acids derived from a region between the 
transmembrane domain and the N ter-
minus of each D1 domain, named the , January 23, 2009 ©2009 Elsevier Inc. 213
“wedge,” directly interacts 
with the D1 catalytic pocket 
of the partner protein. This 
results in reciprocal steric hin-
drance of the catalytic pock-
ets (Figure 1). This model was 
supported by other work, such 
as by Majeti et al. (1998), who 
showed that a single muta-
tion in this wedge domain 
increases the in vivo activity of 
a hybrid EGFR-CD45. Xie et al. 
(2006) also reported that pep-
tides derived from the wedge 
region of LAR (leukocyte anti-
gen-related protein tyrosine 
phosphatase) and PTPµ medi-
ate homophilic interactions 
and reduce homodimeriza-
tion, resulting in an increase in 
PTP catalytic activity.
Based on their study, Barr 
et al. (2009) reject the exis-
tence of such an inhibitory 
wedge domain. In contrast 
to the “wedge” model, the 
RPTPγ crystal of the com-
plete intracellular region reveals an inter-
action between the D1 domain of one 
of the partners in the dimer with the D2 
domain of the other. They recognize the 
region between the D1 domain and the 
transmembrane domain not as a wedge 
but as a linker segment that provides 
sufficient flexible space to allow turning 
of the full PTP internal domain by 90°. 
Turning permits a head-to-toe interaction 
with the other partner in the dimer. D1-D2 
recognition had also been observed by 
Wallace et al. (1998), who used the D1 
domain of RPTPσ as bait in a two-hybrid 
screen and identified the D2 domain of 
the close homolog RPTPδ as an interact-
ing partner. This D1-D2 interaction was 
considerably weakened by the removal 
of the wedge domain from the D1 bait 
construct. Yet this finding and the biolog-
ical effects of wedge-derived peptides 
observed by Xie et al. (2006) still hint at a 
possible contribution of this intracellular 
region to the dimerization process.
The work of Barr et al. allows the exami-
nation of a plethora of posttranslational 
modifications that control PTP activity, 
including phosphorylation, ubiquitination, 
proteolytic cleavage, and oxidation. Oxida-
tion of PTPs, for example, causes various 
conformational changes that have a major 
impact on enzyme activity. Indeed, Groen 
et al. (2008) recently confirmed that oxida-
tion of RPTPs causes extensive conforma-
tional changes in the cytoplasmic domains 
that stabilize the inactive state. Further 
progress in crystallography will eventually 
lead to examination of the role of the trans-
membrane domain of receptor PTPs, such 
as the transmembrane domain of PTPRR 
that is reported to promote the dimeriza-
tion process (Noordman et al., 2008). The 
availability of a growing pool 
of PTP structures is of great 
interest, and the 22 new struc-
tures concurrently published 
by Barr and colleagues will 
have an extraordinary impact 
on the daily efforts of a great 
number of researchers work-
ing on PTPs. In particular, 
those seeking to develop new 
PTP inhibitors stand to gain 
from this expanded toolbox of 
structures, bringing the broad 
clinical application of thera-
peutics that target PTPs one 
step closer.
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Figure 1. Dimerization Models of a Receptor Protein Tyrosine 
 Phosphatase.
(Left) Depiction of a (R5-like) monomeric active receptor protein tyrosine 
phosphatase (RPTP) containing an extracellular segment with a carbonic an-
hydrase motif (CA) and a fibronectin-like element (FN). The extracellular por-
tion is linked through a transmembrane segment to the intracellular domain 
composed of a proximal catalytic motif (D1) and a distal catalytic motif (D2). 
(Middle) An inactive PTP dimer is shown based on the “wedge” model of in-
hibition that results from D1-D1 interactions. (Right) An inactive PTP dimer is 
shown based on the “head-to-toe” model of inhibition in which the D1 domain 
of each monomer interacts with the D2 domain of the other monomer.214 Cell 136, January 23, 2009 ©2009 Elsevier Inc.
